Moderna (MRNA) to Replace Alexion (ALXN) in S&P 500

(Updated - July 15, 2021 5:18 PM EDT)

Moderna Inc. (NASDAQ: MRNA) will replace Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) in the S&P 500 effective prior to the opening of trading on Wednesday, July 21. AstraZeneca Plc (LSE:AZN; NASDAQ:AZN) is acquiring Alexion Pharmaceuticals in a deal expected to be completed soon pending final closing conditions.

You May Also Be Interested In

• First Advantage to join S&P SmallCap 600, replacing Kennedy-Wilson
• Robinhood experiences service disruptions amid record traffic
• Flex to join S&P 500 index effective June 22